Advisory Research’s Celestica CLS Stock Holding History

Advisory Research’s Portfolio CLS Stock Details CLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-21,208	Closed	-$207K	–	362
2022 Q2	$207K	Sell	21,208 -97	-0.5%	-$1.04K	0.02%	303
2022 Q1	$254K	Buy	+21,305	New	+$251K	0.02%	321

Other funds holding CLS

LBA

Letko, Brosseau & Associates Montreal, Quebec, Canada $6.2B AUM 38.92% 1-Year Est. Return

Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return

DSC

Donald Smith & Co New York $5.56B AUM 47.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

HIM

Hillsdale Investment Management Toronto, Ontario, Canada $3.68B AUM 62.12% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

SRAIM

Scheer Rowlett & Associates Investment Management Toronto, Ontario, Canada $1.39B AUM 49.24% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Advisory Research's CLS Position: Q3 2022 in Review

Advisory Research sold out of Celestica (CLS) in Q3 2022, closing a stake of 21,208 shares — an estimated $207K sold.

Advisory Research first reported a position in CLS in Q1 2022 and held it in 2 quarters. The position peaked at $254K in Q1 2022. 138 funds tracked by Wall St. Rank hold CLS as of Q3 2022.

Advisory Research reported no remaining Celestica position as of Q3 2022 after selling out during the quarter.
Advisory Research sold 21,208 Celestica shares in Q3 2022, an estimated $207K.
Advisory Research first reported a position in Celestica in Q1 2022 and held it in 2 quarters.
Advisory Research's Celestica position peaked at $254K in Q1 2022.
138 funds tracked by Wall St. Rank held Celestica as of Q3 2022.

Based on Advisory Research's 13F filing for Q3 2022, filed 15 Nov 2022.